Amgen invests in precision oncology startup Syapse

You are here: Home > Central Coast Health Watch > Current Article

Amgen invests in precision oncology startup Syapse

By Staff Report / Monday, November 20th, 2017 / Comments Off on Amgen invests in precision oncology startup Syapse

Amgen investment arm Amgen Ventures participated in a $30 million funding round for San Francisco precision oncology startup Syapse. The Thousand Oaks-based biotech giant joined several other investors, including Ascension Ventures, GE Ventures, Intermountain Healthcare Innovation Fund, Roche Venture Fund, Merck Global Health and others, Syapse announced Nov. 14. The Series D financing round will…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.